Drug repurposing identifies proteasome inhibitors as antiproliferative agents counteracting inflammation-driven chemoresistance in triple-negative breast cancer organoids

7

punsarn.item.page.citation

Sari A.I.P., Roytrakul S., Chittavanich P., Saengwimol D., Laosillapacharoen N., Khamjerm J., Borwornpinyo S., Jinawath A., Suvikapakornkul R., Lertsithichai P., Chirappapha P., Jinawath N., Kaewkhaw R. Drug repurposing identifies proteasome inhibitors as antiproliferative agents counteracting inflammation-driven chemoresistance in triple-negative breast cancer organoids. Biomedicine and Pharmacotherapy Vol.190 (2025). doi:10.1016/j.biopha.2025.118359 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/111387

item.page.availability

Collections